INSERT YOUR ANALYTICS CODES HERE
Cardiovascular Technology Space

CARDIOVASCULAR SPACE

The United States’ segment for medical devices is expected to grow at a compound annual growth rate of 6.1% over the next four years. A good part of this jump in growth is due to the 85.6 million individuals in the country who suffer from cardiovascular disease.

An aging population, combined with unhealthy lifestyle choices, has drastically increased diagnosed cases of cardiovascular and circulatory diseases. Instances of mortality due to heart disease are on the rise both domestically and globally. In the last year, more than 17 million individuals have perished worldwide due to cardiovascular illness.

Emerging Technological Trends

The cardiovascular device sector is working on technologies designed to reduce instances of death and increase the longevity and quality of life for those afflicted with cardiac diseases.

Minimally invasive technology is the biggest emerging trend in cardiovascular devices, particularly in ventricle assist devices. The small nature of these new assistive cardiac devices reduces the need for a separate pocket to hold the pump, adding to convenience and reducing complications.

Ventricle assist devices are also being developed to be magnetically levitated, minimizing the invasive nature of typical cardiac surgeries and the complications and morbidity that can come with such procedures. Pacemakers are being designed to be more responsive to individual patient needs, by automatically emitting low electrical pulses when irregular heartbeats are detected.

Along with this new automatic nature, patients now have more control over their own health and maintenance with pacemakers that they themselves can turn on and off. All these device improvements are aimed at reducing the need for anticoagulant pharmaceuticals, which are highly associated with blood clots and further medical complications.

INCREASE EFFICIENCY

HOW SARITASA HELPS

INCREASE EFFICIENCY

The Impact of IoT on Cardiovascular Devices

The largest technology trend predicted to drive growth and development in the Cardiovascular Medical Devices sector is the integration of these devices into a connected platform.

Both end users and physicians alike are increasingly demanding that the devices implanted in and used by patients have remotely accessible qualities, primarily in the form of monitoring.

These monitoring capabilities manifest in mobile devices that allow physicians to easily track patient vitals and securely access and transfer health records and data. Remote monitoring of cardiac devices is more efficient and cost saving for both patients and physicians/hospitals.

Devices with these capabilities have been found to decrease the annual cost per patient by up to 54.87%. Money is primarily saved by reducing incidents of hospitalization and maintenance costs, as most upkeep and tracking of a patient’s vitals and status can be done from the comfort of a tablet or mobile device.

HOW SARITASA HELPS

Saritasa: Your Digital Cardiovascular Tech Partner

Saritasa efficiently implements the design, development and integration of complex technologies to deliver cost-effective mobile-to-medical device connectivity solutions that are FDA/HIPAA compliant.

Founded in 2005 and located in Newport Beach, CA, Saritasa has increasingly become the single-point-of-contact to deliver end-to-end solutions that integrate, IoT, Mobile Apps, Medical Device Connectivity Solutions, Cloud Services Integrations, Big Data, Analytics, and Reporting solutions.

Our clients include some of the leading Cardiovascular Medical Device makers that have come to rely on our expertise, reliability and speed for bringing innovative ideas to reality. To date, our innovative team of 140 designers, developers, engineers, and project managers has delivered hundreds of successful software, hardware, and mobile app projects to the Medical Device industry.

WHO
WE ARE

main image